tetraethylammonium has been researched along with Postthrombotic Syndrome in 1 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
Postthrombotic Syndrome: A condition caused by one or more episodes of DEEP VEIN THROMBOSIS, usually the blood clots are lodged in the legs. Clinical features include EDEMA; PAIN; aching; heaviness; and MUSCLE CRAMP in the leg. When severe leg swelling leads to skin breakdown, it is called venous STASIS ULCER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| GIUNTA, A | 1 |
| MORETTINI, A | 1 |
1 other study available for tetraethylammonium and Postthrombotic Syndrome
| Article | Year |
|---|---|
[Studies on cutaneous hemorrhage induced by venous stasis. VI. Effect of intra-arterial tetraethylammonium bromide].
Topics: Postthrombotic Syndrome; Purpura; Tetraethylammonium | 1955 |